2-Quinolyl- and 3-quinolyl-cyanocombretastatin analogs exhibit potent growth inhibition against a panel of 60 human cancer cell lines.
No takes yet. Share an insight, caveat, or question.
Penthala et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: